Download - Chapter 13
![Page 1: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/1.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc.
Chapter 13
Assessment and Care of Patients with Fluid and Electrolyte Imbalances
![Page 2: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/2.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 2
Homeostasis
Extracellular fluid Intracellular fluid Interstitial fluid Transcellular fluids
![Page 3: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/3.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 3
Clinical Significance: Blood Pressure
Blood pressure is an example of hydrostatic filtering forces. It moves whole blood from the heart to capillaries where filtration can occur to exchange water, nutrients, and waste products between the blood and the tissues.
![Page 4: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/4.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 4
Blood Pressure
QuickTime™ and aYUV420 codec decompressor
are needed to see this picture.
![Page 5: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/5.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 5
Clinical Significance: Edema
Edema develops with changes in normal hydrostatic pressure differences.
![Page 6: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/6.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 6
Fluid Balance
QuickTime™ and aYUV420 codec decompressor
are needed to see this picture.
![Page 7: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/7.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 7
Clinical Significance: Diffusion
Diffusion is important in the transport of most electrolytes and particles through cell membranes.
Sodium pumps. Glucose cannot enter most cell
membranes without the help of insulin.
![Page 8: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/8.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 8
Clinical Significance: Osmosis and Filtration
The thirst mechanism is an example of how osmosis helps maintain homeostasis.
The feeling of thirst is caused by the activation of cells in the brain that respond to changes in ECG osmolarity.
![Page 9: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/9.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 9
Fluid Balance
Fluid intake Fluid loss:
Minimum amount of urine needed to excrete toxic waste products is 400 to 600 mL
Insensible water loss
![Page 10: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/10.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 10
Hormonal Regulation of Fluid Balance
Aldosterone Antidiuretic hormone Natriuretic peptides
![Page 11: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/11.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 11
Dehydration
Fluid intake is less than what is needed to meet the body’s fluid needs, resulting in a fluid volume deficit.
Consideration for older adults.
![Page 12: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/12.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 12
Collaborative Care—Dehydration
Assessment History Physical assessment/clinical
manifestations: Cardiovascular changes Respiratory changes Skin changes Neurologic changes Renal changes
![Page 13: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/13.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 13
Dehydration: Laboratory Assessment
Elevated hemoglobin Elevated hematocrit Elevated serum osmolarity Elevated glucose Elevated protein Elevated BUN Elevated electrolytes Hemoconcentration
![Page 14: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/14.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 14
Dehydration: Interventions Patient safety Fluid replacement Drug therapy
QuickTime™ and aYUV420 codec decompressor
are needed to see this picture.
![Page 15: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/15.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 15
Fluid Overload
Excess of body fluid. Most problems caused
by overhydration are related to fluid volume excess in the vascular space or to dilution of specific electrolytes and blood components.
![Page 16: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/16.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 16
Collaborative Care—Fluid Overload
Assessment Patient safety Pulmonary edema Drug therapy Nutrition therapy Monitoring of I&O
![Page 17: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/17.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 17
Sodium (135 to 145 mmol/L)
Sodium level is vital for skeletal muscle contraction, cardiac contraction, nerve impulse transmission, and normal osmolarity and volume of the ECF.
![Page 18: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/18.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 18
Hyponatremia
Sodium level below 136 mEq/L Cerebral changes Neuromuscular changes Intestinal changes Cardiovascular changes
![Page 19: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/19.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 19
Hyponatremia Interventions
The priority for nursing care of the patient with hyponatremia is monitoring the patient’s response to therapy and preventing hypernatremia and fluid overload.
Drug therapy. Nutrition therapy.
![Page 20: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/20.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 20
Hypernatremia
Serum sodium level over 145 mEq/L Nervous system changes Skeletal muscle changes Cardiovascular changes
![Page 21: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/21.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 21
Hypernatremia Interventions
Priorities for nursing care of the patient with hypernatremia include monitoring the patient's response to therapy and preventing hyponatremia and dehydration.
Drug therapy. Nutrition therapy.
![Page 22: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/22.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 22
Potassium (3.5 to 5.0 mEq/L)
Depolarization and generation of action potentials, as well as regulating protein synthesis and glucose use and storage
![Page 23: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/23.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 23
Hypokalemia
Serum potassium level below 3.5 mEq/L Can be life threatening because every
body system is affected Respiratory changes Musculoskeletal changes Cardiovascular changes Neurologic changes Intestinal changes
![Page 24: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/24.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 24
Hypokalemia Interventions
The priorities for nursing care of the patient with hypokalemia are ensuring adequate oxygenation and patient safety for falls prevention, preventing injury from potassium administration, and monitoring the patent's response to therapy.
Drug therapy. Nutrition therapy. Safety measures. Respiratory monitoring.
![Page 25: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/25.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 25
Hyperkalemia
Serum potassium greater than 5.0 mEq/L. Cardiovascular changes are the most
severe problems from hyperkalemia and are the most common cause of death in patients with hyperkalemia.
Neuromuscular changes. Intestinal changes.
![Page 26: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/26.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 26
Hyperkalemia Interventions
Drug therapy—Kayexalate, insulin Cardiac monitoring Health teaching
![Page 27: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/27.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 27
Calcium (9.0 to 10.5 mg/dL)
Calcium is a mineral with functions closely related to those of phosphorus and magnesium.
Absorption of dietary calcium requires the active form of vitamin D.
Calcium is stored in the bones. Parathyroid hormone. Thyrocalcitonin.
![Page 28: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/28.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 28
Hypocalcemia
Total serum calcium level below 9.0 mg/dL Cultural considerations Women’s health considerations Neuromuscular changes
![Page 29: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/29.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 29
Hypocalcemia (Cont’d)
![Page 30: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/30.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 30
Hypocalcemia (Cont’d)
Cardiovascular changes Intestinal changes Skeletal changes
![Page 31: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/31.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 31
Hypocalcemia Interventions
Drug therapy Nutritional therapy Environmental management—seizure
precautions Injury prevention strategies
![Page 32: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/32.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 32
Hypercalcemia
Total serum calcium level above 10.5 mg/dL.
Effects of hypercalcemia occur first in excitable tissues.
All systems are affected.
![Page 33: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/33.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 33
Hypercalcemia (Cont’d)
Cardiovascular changes are the most serious and life-threatening problems of hypercalcemia.
Neuromuscular changes. Intestinal changes.
![Page 34: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/34.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 34
Hypercalcemia Interventions
Drug therapy—IV 0.9% sodium chloride, furosemide, calcium chelators, phosphorus, calcitonin, bisphosphonates, and prostaglandin synthesis inhibitors
Dialysis Cardiac monitoring
![Page 35: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/35.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 35
Phosphorus (3.0 to 4.5 mg/dL)
Most phosphorus can be found in the bones.
Phosphorus is needed for activating vitamins and enzymes, forming adenosine triphosphate, and assisting in cell growth and metabolism.
Food sources include meats, fish, dairy products, and nuts.
Plasma levels of calcium and phosphorus exist in a balanced reciprocal relationship.
![Page 36: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/36.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 36
Hypophosphatemia
Serum phosphorus level below 3.0 mEq/L. Most of the effects of hypophosphatemia
are related to decreased energy metabolism and imbalances of other electrolytes and body fluids.
![Page 37: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/37.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 37
Hypophosphatemia (Cont’d)
Manifestations are most apparent in the cardiac, musculoskeletal, and hematologic systems and the CNS.
Cardiac changes. Musculoskeletal changes—
rhabdomyolysis. CNS changes.
![Page 38: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/38.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 38
Hypophosphatemia Interventions
Oral replacement of phosphorus Vitamin D supplements IV phosphorus Nutrition therapy—increasing the intake of
phosphorus-rich foods while decreasing the intake of calcium-rich foods
![Page 39: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/39.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 39
Hyperphosphatemia
Serum phosphorus level above 4.5 mEq/L. Problems caused by hyperphosphatemia
center on the hypocalcemia that results when serum phosphorus levels increase.
Does not cause many direct problems with body function.
Causes include renal insufficiency, certain cancer treatments, increased phosphorus intake, and hypoparathyroidism.
![Page 40: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/40.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 40
Hyperphosphatemia Interventions
Because calcium and phosphorus ions exist in the blood in a balanced reciprocal relationship, management of hyperphosphatemia entails the management of hypocalcemia.
![Page 41: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/41.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 41
Magnesium (1.3 to 2.1 mg/dL)
Magnesium is critical for skeletal muscle contraction, carbohydrate metabolism, ATP formation, vitamin activation, and cell growth.
![Page 42: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/42.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 42
Hypomagnesemia
Serum magnesium level below 1.2 mEq/L. Effects of hypomagnesemia are caused by
increased membrane excitability and the accompanying serum calcium and potassium imbalances.
![Page 43: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/43.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 43
Hypomagnesemia (Cont’d)
Neuromuscular changes. CNS changes. Intestinal changes. Interventions for hypomagnesemia:
Drugs—IV magnesium sulfate
![Page 44: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/44.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 44
Hypermagnesemia
Serum magnesium level above 2.1 mEq/L. When magnesium excess occurs,
excitable membranes are less excitable and need a stronger-than-normal stimulus to respond.
Cardiac changes. CNS changes. Neuromuscular changes. Respiratory changes.
![Page 45: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/45.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 45
Hypermagnesemia Interventions
Magnesium-free IV fluids Furosemide Calcium
![Page 46: Chapter 13](https://reader035.vdocuments.us/reader035/viewer/2022062813/56816582550346895dd8244e/html5/thumbnails/46.jpg)
Elsevier items and derived items © 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 46
Chloride (98 to 106 mEq/L)
Imbalances of chloride usually occur as a result of other electrolyte imbalances.
Usually corrected by interventions for correcting other electrolyte or acid-base problems.